Nature Cancer – Sears and colleagues found that ongoing replication stress pathways and T cell clonal responses differentiate liver and lung recurrence and are associated with different clinical…
In a Peer Exchange, HCC experts discussed how new data from the HIMALAYA, LEAP-012, EMERALD-1, and IMbrave050 trials could be used to optimize treatment.
Chan Cheah, MBBS, FRACP, FRCPA, DMSc, Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Australia, comments on the preliminary efficacy and safety of the…
Harald Kittler, MD, Medical University of Vienna, Vienna, Austria, comments on the current challenges in the clinical implementation of artificial intelligence (AI) for the diagnosis…
This Viewpoint discusses strategies used with driving that can be applied to health care to promote consistent and predictable physician and patient actions.
Matthew Hadfield, DO, discusses findings from a phase 2 study that used tocilizumab to reduce toxicities with immune checkpoint inhibitors in melanoma.
Both dose levels of modakafusp alfa “resulted in good response rates with similar safety profiles,” according to researchers.
Geoffrey Hill, MD, FRACP, FRCPA, was recently announced as the recipient of the Leonard and Norma Klorfine Endowed Chair for Clinical Research at Fred Hutch…
